Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptualsian.com shared his views and outlook on the fundamentals of the markets and specific stocks.
Ashwani Gujral of ashwanigujral.com recommends buying Tata Global Beverage and Aurobindo Pharma.
Ashwani Gujral of ashwanigujral.com is of the view that one may buy Aurobindo Pharma and Welspun India and can sell Britannia Industries.
Ashwani Gujral of ashwanigujral.com is of the view that one may buy Ceat, Central Bank of India and Motherson Sumi and can sell HPCL and SRF.
Ashwani Gujral of ashwanigujral.com suggests buying PNB, Bajaj Finance and Piramal Enterprises and expects Lupin to test Rs 1300.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian shared his views and outlook on the fundamentals of the market ans specific stocks.
In an interview to CNBC-TV18, Rahul Arora, CEO at Nirmal Bang Institutional Equities shared his readings and outlook on the market and specific stocks and sectors.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks.
Ashwani Gujral of ashwanigujral.com recommends buying Edelweiss Financial, IGL and Aurobindo Pharma.
In the last nine months to one year time, the pharma stock prices were plummeted by 20-35 percent.
Rahul Shah of Motilal Oswal recommends buying JSW Steel, Can Fin Homes and Aurobindo Pharma.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Aurobindo Pharma and Apollo Tyres and can sell Pidilite Industries.
Sudarshan Sukhani of s2analytics.com is of the view that one can short Punjab National Bank and can buy Aurobindo Pharma, Dr Reddy's Laboratories and Prabhat Dairy.
According to Sudarshan Sukhani of s2analytics.com, one can sell Hindalco Industries and Arvind and can buy Britannia Industries and Mindtree.
Mitessh Thakkar of miteshthacker.com is of the view that one can buy Reliance Capital, NBCC and Rain Industries and can sell Bajaj Finserv below Rs 4080.
Morgan Stanley feels Vedanta's favorable commodity exposure and robust volume growth bode well for earnings and cash flows.
Ashwani Gujral of ashwanigujral.com advises buy Escorts, LIC Housing and Can Fin Homes.
Ashwani Gujral of ashwanigujral.com advises selling Ceat and Coal India.
Formulations plant of Dr Reddy's Laboratories at Srikakulam gets inspected and gets 1 observation from United States Foods and Drug Authority (US-FDA). The plant was inspected with zero observations last time.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian ofsptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
Ashwani Gujral of ashwanigujral.com recommends buying Max Financial Services, BGR Energy Systems and KEC International and advises holding Avenue Supermarts.
Sandeep Wagle of powermywealth.com recommends buying Federal Bank and India Cements and feels that Aurobindo Pharma may test Rs 730.
Ashwani Gujral of ashwanigujral.com is of the view that Aditya Birla Money hit Rs 80 and advises not to go after pharma stocks.
According to Ashwani Gujral of ashwanigujral.com, one can buy BPCL, India Cements and UPL and feels that Aurobindo Pharma may test Rs 700.